Roberta Maggio Selected Research

Roberta Maggio Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 04/2011
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2011 - 02/2007
2	Leukemia 04/2020 - 04/2011
2	Non-alcoholic Fatty Liver Disease 10/2014 - 11/2013
2	Fibrosis (Cirrhosis) 04/2011 - 09/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2008 - 06/2007
2	Pathologic Complete Response 02/2007 - 06/2005
1	Adrenocortical Carcinoma 06/2023
1	Hypogonadism (Hypergonadotropic Hypogonadism) 06/2023
1	Intellectual Disability (Idiocy) 01/2023
1	Abdominal Pain (Pain, Abdominal) 01/2023
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Adrenal incidentaloma 01/2022
1	Adenoma (Adenomas) 01/2022
1	Addison Disease (Addison's Disease) 06/2021
1	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2020
1	Melanoma (Melanoma, Malignant) 02/2019
1	Necrosis 01/2019
1	Glioma (Gliomas) 12/2017
1	Skin Diseases (Skin Disease) 01/2017
1	Liver Diseases (Liver Disease) 01/2014
1	Infections 01/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2014
1	Virus Diseases (Viral Diseases) 01/2014
1	Chronic Hepatitis C 01/2014
1	Mucocutaneous Leishmaniasis 08/2012
1	Philadelphia Chromosome 04/2011
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2011
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 09/2009
1	Spontaneous Remission 07/2009
1	Disease Progression 08/2008
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2007

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 04/2020 - 01/2017
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2021 - 04/2011
2	EndocannabinoidsIBA 04/2011 - 09/2009
2	CannabinoidsIBA 04/2011 - 09/2009
1	Mitotane (Lysodren)FDA Link 06/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	obinutuzumabIBA 04/2020
1	Immunoglobulin Fc FragmentsIBA 04/2020
1	AntibodiesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	VaccinesIBA 02/2019
1	Cancer VaccinesIBA 02/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 01/2019
1	ChemokinesIBA 12/2017
1	oleuropeinIBA 10/2014
1	Olive OilIBA 10/2014
1	AntioxidantsIBA 10/2014
1	LipidsIBA 10/2014
1	PolyphenolsIBA 10/2014
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	CholesterolIBA 01/2014
1	Dietary CholesterolIBA 01/2014
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2013
1	Tyrosine (L-Tyrosine)FDA Link 04/2011
1	Hydroxyproline (4 Hydroxyproline)IBA 04/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2011
1	Imatinib Mesylate (Gleevec)FDA Link 04/2011
1	Cannabinoid Receptor AgonistsIBA 04/2011
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2009
1	Interleukin-4 (Interleukin 4)IBA 07/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2009
1	Immunoglobulin M (IgM)IBA 08/2008
1	MicroRNAs (MicroRNA)IBA 06/2007
1	OligonucleotidesIBA 05/2007
1	Interleukin-12 (IL 12)IBA 06/2005
1	Interleukin-15 (Interleukin 15)IBA 06/2005
1	InterleukinsIBA 06/2005

Therapy/Procedure

4	Therapeutics 06/2021 - 02/2007
2	Ligation 04/2020 - 08/2008
1	Medical Day Care (Partial Hospitalization) 01/2023
1	Immunotherapy 01/2020
1	Combined Modality Therapy 01/2014
1	Injections 04/2011